Spring Pop Up,Spring Pop Up Banner Stands,Advertising Roll Up Banner,Exhibition Wall Banner Display Stand SUZHOU JH DISPLAY&EXHIBITION EQUIPMENT CO.,LTD , https://www.jh-popup.com
After a sustained high-speed growth for several years, China's pharmaceutical preparations have basically entered a period of stable growth. The transition from raw material medicines to preparations exports takes a longer period of time. Chinese preparations have entered an international perspective. In addition to providing quality varieties, companies need to establish good marketing channels and develop international market layouts.
In fact, as early as 2005, Chinese pharmaceutical companies began to enter the international perspective with subsidiaries or joint ventures and cross-border mergers and acquisitions. However, after all, they were still 15 years behind India and other competitors. Product registration, documentation, channels There are huge gaps in the establishment, generic drug development, and patent challenges. As a result, Chinese pharmaceutical preparations account for a relatively low percentage of imports in the developed countries, accounting for only about 1% of the imports of developed countries such as the United States, Japan, and the United Kingdom.
In addition, due to the different regulatory models, there are few public procurement channels for Chinese pharmaceutical preparations entering emerging market countries. It is difficult to pass the WHOPQ certification and many companies have lost access to the African market through international procurement channels. The differences in the ASEAN market supervision system, the unclear registration system, the difficulties in the construction of marketing channels, and the language barriers in the South American market have also increased the difficulties in the development of emerging markets.
Therefore, in the preparation of international markets for pharmaceutical preparations in China, in addition to the need for both developed and emerging markets, it is also necessary to conduct reasonable capital operations and seek support for policy funds, so as to have sufficient strength to rapidly expand product development and production lines. The rationalization of the distribution of drugs is the development track of giants of global generic pharmaceutical companies.
In recent years, China has also implemented a number of policies and financial support to encourage companies to develop the internationalization of pharmaceutical preparations, provide industrial transformation and upgrading, and a large number of enterprises such as Huahai, Hisun, and Jingxin Pharmaceutical have also received financial support from the country to varying degrees. However, it is undeniable that there are still varying degrees of problems in the field of commissioned processing, foreign registration, and export supervision in the field of pharmaceutical preparations. It is necessary for the government, industry, and the enterprise to jointly promote the development of the foreign trade of pharmaceutical preparations.
China's pharmaceutical preparation enterprises need international funds to "charge"
In recent years, China has also implemented a number of policies and financial support to encourage companies to develop the internationalization of pharmaceutical preparations, provide industrial transformation and upgrading, and a large number of enterprises such as Huahai, Hisun, and Jingxin Pharmaceutical have also received financial support from the country to varying degrees.